Status:
UNKNOWN
The Role of Cathepsin X in Infection With the Helicobacter Pylori
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Persistence of Infection With Helicobacter Pylori
Eligibility:
All Genders
18-65 years
Brief Summary
The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonst...
Eligibility Criteria
Inclusion
- People with helicobacter gastritis and Helicobacter sensitive to antibiotic therapy but failure of therapy -
Exclusion
- People with helicobacter gastritis who did not eradicate Helicobacter pylori because of primary resistance to antibiotics.
- \-
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01137942
Start Date
November 1 2008
End Date
July 1 2010
Last Update
July 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abakus Medico
Rogaška Slatina, Slovenia